News and Announcements
E-health Play Alcidion Makes Debut
- Published March 01, 2016 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th February 2016, Yahoo News By Nick Evans
Nathan Buzza’s latest IT venture has launched onto the Australian Securities Exchange today.
E-health provider Alcidion Group began trading with a market capitalisation of about $35 million.
Serial technology entrepreneur Mr Buzza is best known for Commtech Wireless, sold in 2008 to Amcom Software.
His latest venture centralises patient health data, such as hospital pathology and oncology records onto mobile devices, which Alcidion claims will help clinicians make better decisions about patient care and avoid medical errors.
To view the full article, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
